Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats.
about
Tumor-specific microsatellite instability: do distinct mechanisms underlie the MSI-L and EMAST phenotypes?Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicityChemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients.Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.Functional analysis in mouse embryonic stem cells reveals wild-type activity for three MSH6 variants found in suspected Lynch syndrome patients.Anticipation in lynch syndrome: where we are where we goB-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.Microsatellite instability use in mismatch repair gene sequence variant classificationEvaluation of a new panel of six mononucleotide repeat markers for the detection of DNA mismatch repair-deficient tumours.Evaluation of colorectal cancers for Lynch syndrome: practical molecular diagnostics for surgical pathologists.New use of microsatellite instability analysis in endometrial cancer.Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome.Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer.Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
P2860
Q26864622-1B7F6637-7B05-41CA-B6DB-CD24DD835032Q28085485-355AD4DE-884B-4731-A41E-64F6516B4532Q33769290-8A8D3786-6229-4069-B660-F3F8591DDA7DQ34659119-35D77911-1638-4ACA-99F5-C124839A5D7AQ34785026-C6798C67-569F-4FAC-B4BB-73706161F242Q34961153-1FEF6809-FD4F-43B5-8B11-9ADC4E281CB4Q34990339-6113FE0E-5801-4976-B557-CE337750A267Q35560811-A28B961A-B258-4C7A-93E4-86847042AE3FQ35677252-BD464C63-EF17-4899-9F91-D4C79F724485Q35808472-EC3D6087-A1F1-4CD5-98FA-945D0D6891C0Q36896145-A135C962-8774-4F44-8991-E0097D43010DQ38308050-B5E8A796-1280-483C-9470-7C1B77F71D81Q41619058-21184DE7-3B63-46B5-BB67-758CE41AA64FQ45400063-8398B586-AE87-41DD-937B-F9F56860EC35Q49452061-628F61B7-9047-452F-9C49-D9B5AEC65E32Q58806091-AE280228-0F29-4381-94B4-2E40AC2234B8
P2860
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@ast
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@en
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@nl
type
label
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@ast
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@en
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@nl
prefLabel
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@ast
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@en
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@nl
P2093
P2860
P356
P1476
Tumours with loss of MSH6 expr ...... f five mononucleotide repeats.
@en
P2093
J-F Flejou
M J L Ligtenberg
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605988
P407
P577
2010-11-16T00:00:00Z
P5875
P6179
1049191281